ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 188 filers reported holding ADMA BIOLOGICS INC in Q3 2023. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $671,608 | -3.0% | 187,600 | 0.0% | 0.00% | – |
| Q2 2023 | $692,244 | +88.1% | 187,600 | +68.7% | 0.00% | – |
| Q1 2023 | $368,072 | -14.7% | 111,200 | 0.0% | 0.00% | – |
| Q4 2022 | $431,456 | +285.2% | 111,200 | +141.7% | 0.00% | – |
| Q3 2022 | $112,000 | +124.0% | 46,000 | +82.5% | 0.00% | – |
| Q2 2022 | $50,000 | -65.3% | 25,200 | -69.3% | 0.00% | – |
| Q1 2021 | $144,000 | -10.6% | 82,000 | -0.8% | 0.00% | – |
| Q4 2020 | $161,000 | -37.8% | 82,700 | -23.8% | 0.00% | – |
| Q3 2020 | $259,000 | -52.2% | 108,500 | -41.3% | 0.00% | – |
| Q2 2020 | $542,000 | +107.7% | 184,900 | +104.3% | 0.00% | – |
| Q1 2020 | $261,000 | +177.7% | 90,500 | +283.5% | 0.00% | – |
| Q4 2019 | $94,000 | -10.5% | 23,600 | 0.0% | 0.00% | – |
| Q3 2019 | $105,000 | +15.4% | 23,600 | 0.0% | 0.00% | – |
| Q2 2019 | $91,000 | – | 23,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Velan Capital Investment Management LP | 4,000,000 | $13,240,000 | 11.29% |
| Stonepine Capital Management, LLC | 7,661,690 | $25,360,194 | 8.50% |
| Altium Capital Management LP | 2,870,000 | $9,499,700 | 5.27% |
| Caligan Partners LP | 1,662,613 | $5,503,249 | 3.84% |
| AWM Investment Company, Inc. | 6,015,000 | $19,909,650 | 2.69% |
| Perceptive Advisors | 11,900,255 | $39,389,844 | 1.16% |
| EAM Investors, LLC | 1,035,752 | $3,428,339 | 0.67% |
| OBERWEIS ASSET MANAGEMENT INC/ | 1,169,500 | $3,871,045 | 0.60% |
| Magnetar Financial LLC | 7,074,722 | $23,417,330 | 0.46% |
| Virtus ETF Advisers LLC | 83,925 | $277,792 | 0.15% |